Reported 110 shares, down 5,413 (98.0%) from the prior quarter.
Reported value -75.8%; share count -98.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2024-12-31 | 331 |
| 2025-03-31 | 80 |
| 2025-06-30 | 0 |
| 2025-06-30 | 173 |
| 2025-09-30 | 92 |
| 2025-12-31 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q4 2025 | Reduced | 0 | -18 (-100.0%) | 0 | $0 | 2026-02-03 | |
| Q3 2025 | Unchanged | 18 | 0 (0.0%) | < 0.01% | $92 | 2025-11-05 | |
| Q2 2025 | New | 18 | +18 (0.0%) | < 0.01% | $173 | 2025-08-08 | |
| Q2 2025 | Reduced | 0 | -110 (-100.0%) | 0 | $0 | 2025-08-08 | |
| Q1 2025 | Reduced | 110 | -5,413 (-98.0%) | < 0.01% | $80 | 2025-05-02 | |
| Q4 2024 | New | 5,523 | +5,523 (0.0%) | < 0.01% | $331 | 2025-02-06 |
Who else reported the position
15 managers reported CERO THERAPEUTICS HLDGS INC for Q1 2025.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL LLC | New | 312,000 | +312,000 | < 0.01% | $227,760 | 1 qtr |
| Parallel Advisors LLC | New | 220,000 | +220,000 | < 0.01% | $160,600 | 1 qtr |
| Avantax Planning Partners Inc | New | 74,321 | +74,321 | < 0.01% | $54,254 | 1 qtr |
| UBS Group AG | New | 42,687 | +42,687 | < 0.01% | $31,162 | 1 qtr |
| ARCH Venture Management LLC | New | 22,102 | +22,102 | < 0.01% | $16,134 | 1 qtr |
| GEODE CAPITAL MANAGEMENT LLC | New | 16,917 | +16,917 | < 0.01% | $12,349 | 1 qtr |
| CITADEL ADVISORS LLC | New | 16,218 | +16,218 | < 0.01% | $11,839 | 1 qtr |
| SUSQUEHANNA INTERNATIONAL GROUP LLP | New | 13,343 | +13,343 | < 0.01% | $9,740 | 1 qtr |
| Tower Research Capital LLC TRC | New | 5,018 | +5,018 | < 0.01% | $3,663 | 1 qtr |
| SBI Securities Co Ltd This report | Reduced | 110 | -5,413 | < 0.01% | $80 | 2 qtrs |
Filing details and methodology As reported
- Report period
- March 31, 2025
- Filed
- May 02, 2025
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 110
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.